FGF21 Inflammation associated with indicators of nutritional status in patients with IBD

Published Date: 03 Mar 2023

FGF21 Inflammation associated with indicators of nutritional status in patients with IBD

Read Full News

Latest News

Health Round: Experimental Blood Test Finds High-risk Colorectal Lesions Before Cancer Develops

We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments.

Constipation Relief: Elobixibat Outperforms Prucalopride

Elobixibat offers faster and greater symptomatic relief than prucalopride among patients with functional constipation unresponsive to first-line treatment.

Pancreatic Cysts: Sparing Use of Invasive Tests Seems Safe

Guidelines call for strict limits on invasive tests for pancreatic cyst surveillance, and a new study supports the strategy’s safety.

Patients’ Wait Times for Cancer Surgeries Keep Growing

Wait times for potentially curative cancer surgery, which have been climbing steadily for more than a decade, have risen particularly rapidly at high-volume academic centers.

Taylor Farms Outbreaks Show Limits Of US Ability to Safeguard Produce From Mexico

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

US Health Agency Moves to Increase Oversight Of Food Additives

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

Todays Updates

Adrenal Incidentalomas: When to Worry and What to Test

Not all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.

Understanding the 'Wait Time Paradox' in Ovarian Cancer

Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.

Adapting Approaches in the Fibromyalgia Landscape

Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.

The Expanding Use of CGM for Diabetes

Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.

Four Signs You Should Biopsy a Skin Lesion, Not Freeze It

Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

FDA Approves Brain-imaging Agent for Alzheimer's Assessment

The FDA has approved a radioactive agent for use ⁠in brain scans to help assess patients for Alzheimer's disease.

Todays Updates

Adrenal Incidentalomas: When to Worry and What to Test

Not all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.

Understanding the 'Wait Time Paradox' in Ovarian Cancer

Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.

Adapting Approaches in the Fibromyalgia Landscape

Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.

The Expanding Use of CGM for Diabetes

Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.

Four Signs You Should Biopsy a Skin Lesion, Not Freeze It

Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

FDA Approves Brain-imaging Agent for Alzheimer's Assessment

The FDA has approved a radioactive agent for use ⁠in brain scans to help assess patients for Alzheimer's disease.

Latest News

We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments.

Elobixibat offers faster and greater symptomatic relief than prucalopride among patients with functional constipation unresponsive to first-line treatment.

Guidelines call for strict limits on invasive tests for pancreatic cyst surveillance, and a new study supports the strategy’s safety.

Wait times for potentially curative cancer surgery, which have been climbing steadily for more than a decade, have risen particularly rapidly at high-volume academic centers.

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

The U.S. Food and Drug Administration on Monday took steps to increase oversight of food additives as part ⁠of the Trump administration's "Make America Healthy Again"...

News All Time

US Cyclosporiasis Probe Linked to Lettuce Widens to 15 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce from central Mexico after detecting cases in six additional states,...

Genetic Marker Linked to Severe Outcomes Across IBD Subtypes

HLA-DRB1*01:03 may serve as a genetic marker for severe outcomes across IBD phenotypes and help identify patients at higher risks for surgery and treatment failure.

Does High-Dose Vitamin D3 Supplementation Improve CRC Survival?

A phase 3 trial was conducted to confirm the benefit of high-dose vitamin D3 supplementation in patients with previously untreated metastatic CRC that was seen in a phase 2 trial.

IV Vitamin C With Chemo Shows Signals in Cancer Care

A phase 2 study reported a longer median overall survival in patients receiving IV ascorbate with chemotherapy, although larger randomized trials are needed to confirm the finding.

Small Colorectal Lesions Carry Risk for Deep Invasion

Non-pedunculated colorectal lesions smaller than 2 cm may harbor deep submucosal invasion despite their diminutive size, study finds.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Does Doublet Chemotherapy Improve Survival in Rectal Cancer?

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Creatinine Assay Bias Affects MELD Scoring

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

EHR Marker May Help Curb Risk for Liver Transplant Rejection

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune Drug Cuts Heavy Drinking in Mid-stage Trial for Alcohol Use Disorder

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

Newer Antibiotics Show No Clear Benefit for Staph Infections

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

FDA Approves Freenome's Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

Company At Center Of US Cyclospora Outbreak Complained to White House, Source Says

U.S. produce supplier Taylor Farms complained to White House and Food and Drug Administration officials about the government's inspection process earlier this month, a...

Poultry Firm Recalls Nearly 1.6 Million Dozen Eggs Over Salmonella Risk, FDA Says

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

CRC Screening in Adults Under 50: Research Reveals Trends

After colorectal cancer screening guidelines were updated in 2021 to lower the screening age to 45, three studies look at how providers are reaching those patients.

Recommended News For You

No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

Breast cancer: A new target to eliminate dormant cells before they wake

Adjuvant ICIs: A Winner and a Loser in Clear Cell Renal Cell Carcinoma?

The main subject is associated with suicide in the United States.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

Hereditary cancer has a rare and underreported cause.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

Recommended Articles For You

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

Everything You Need to Know About the Latest Hyponatremia Algorithm  

Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

2.

Study identifies new target for obesity-related breast cancer

3.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

4.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

5.

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

1.

Unlocking The Power Of Cangrelor To Treat Heart Disease

2.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

3.

Emerging Therapies Using Tumor Evolution Interruption Technologies

4.

Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice

5.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot